Zobrazeno 1 - 10
of 68
pro vyhledávání: '"A. Yu. Savchenko"'
Publikováno v:
Безопасность и риск фармакотерапии, Vol 11, Iss 2, Pp 191-203 (2023)
Several treatment regimens with antituberculosis medicinal products are available for tuberculosis. Thiozonide is a newly developed original antimicrobial agent that exhibits bacteriostatic activity against Mycobacterium tuberculosis strains H37Rv, C
Externí odkaz:
https://doaj.org/article/7d0f4967f53048838d69d12e030f0abb
Autor:
O. A. Eliseeva, M. A. Kolganova, I. E. Shokhin, S. P. Dementyev, A. M. Vlasov, A. A. Zamyatnin, N. S. Dubovik, A. Yu. Savchenko, N. V. Dozmorova, V. G. Luzhanin
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 11, Iss 4, Pp 120-127 (2022)
Introduction. One of the widely used specific anti-HER2 (human epidermal growth factor receptor 2) MAb drugs is trastuzumab. Trastuzumab is highly effective for malignant HER2 hyperexpression reduction, which results in HER2 oncogenicity decrease. As
Externí odkaz:
https://doaj.org/article/85fbef26ae0b43768284bd0f5f5380bc
Autor:
I. A. Pozharnov, A. S. Simakov, N. A. Shulga, A. Yu. Savchenko, O. I. Perederyaev, L. S. Synkova, Yu. V. Medvedev, E. N. Fisher
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 11, Iss 2, Pp 153-158 (2022)
Introduction. Hygienic monitoring of air pollution at the pharmaceutical enterprise required by the law of the Russian Federation (orders, standards, methodological guidelines and guidelines). This requirement follows from the need to protect the per
Externí odkaz:
https://doaj.org/article/5397b2835c6540e3bf3a39e2f88033cd
Autor:
N. S. Dubovik, D. F. Guranda, G. V. Ramenskaya, D. G. Tovbin, D. N. Tarasov, A. Yu. Savchenko, V. S. Arnautov
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 11, Iss 2, Pp 197-206 (2022)
Introduction. Nowadays, discovery and development of innovative drugs represent a relevant goal for the pharmaceutical market. One of such drugs is N-(5-chloropyridine-2-yl)-2-({4-[ethanimidoyl(methyl)benzoyl}amino)-5-methylbenzamide hydrochloride (h
Externí odkaz:
https://doaj.org/article/3e881671b4de4b3392f1ba2a7978d859
Autor:
A. V. Aleshina, T. N. Komarov, O. A. Archakova, D. S. Shchelgacheva, N. S. Bagaeva, V. V. Davydanova, A. Yu. Savchenko, I. E. Shohin
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 10, Iss 2, Pp 120-127 (2021)
Introduction. Tranexamic acid is one of the most common drugs used to stop bleeding after trauma, in surgery and gynecology. The most common analytical method for the determination of this compound is reversed-phase high-performance liquid chromatogr
Externí odkaz:
https://doaj.org/article/09c01da57cdb4c37a74d8cd092d657eb
Autor:
M. A. Kolganova, N. S. Bagaeva, Yu. V. Medvedev, I. E. Shohin, A. V. Demchinskaya, T. N. Palkina, D. A. Salazanov, G. E. Konopleva, M. S. Sheremeteva, Sh. Z. Archuadze, Ya. V. Lavrovsky, A. Yu. Savchenko, M. Yu. Samsonov
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 8, Iss 3, Pp 91-100 (2019)
Introduction. Bevacizumab is a monoclonal IgG1 antibody that binds to and inhibits the biologic activity of human vascular endothelial growth factor (VEGF). Bevacizumab is used as a targeted monoor combination therapy for different solid tumors. Phas
Externí odkaz:
https://doaj.org/article/6934a7f8205e43d19cd8c3495b30f189
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 6, Iss 6, Pp 46-53 (2007)
Aim. To study simvastatin effects on lipid profile and cognitive function in patients with various cerebral ischemia variants. Material and methods. In total, 210 patients with cerebrovascular disease and dyslipidemia (DLP) were divided into three gr
Externí odkaz:
https://doaj.org/article/454385bcdab648a89a8ce806e4a86125
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 10, Iss 8, Pp 98-102 (1970)
The paper is focussed on the drug release comparison for multisource indapamide medications against the original medication, Arifon retard (1,5 mg; Servier Laboratories, France). The comparative test of dissolution kinetics was performed in three med
Externí odkaz:
https://doaj.org/article/9977aced23814d2cb1f56bf57c4ce3fe
Publikováno v:
Pharmacy Formulas. 4:27-42
According to the results of our study, the authors point of view on the problem of testing of radiopharmaceutical medicaments, is reflected, taking into account the active modern development of nuclear medicine. In the context, the issues of the stru
Publikováno v:
Pharmacogenetics and Pharmacogenomics. :42-47
Relevance. In connection with the increase in the number of cases of multidrug-resistant tuberculosis (MDR-TB), the search for new anti-tuberculosis drugs (ATD) is necessary. The assessment of its effect on the human body outside the aspect of the th